H.R.4332 - Generic Drug Application Review Fairness Act of 2012

To amend section 505(j) of the Federal Food, Drug, and Cosmetic Act to extend the period for a first applicant, with respect to a generic drug, to obtain tentative approval without forfeiting the 180-day exclusivity period, and for other purposes. view all titles (2)

All Bill Titles

  • Official: To amend section 505(j) of the Federal Food, Drug, and Cosmetic Act to extend the period for a first applicant, with respect to a generic drug, to obtain tentative approval without forfeiting the 180-day exclusivity period, and for other purposes. as introduced.
  • Short: Generic Drug Application Review Fairness Act of 2012 as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

All Actions
 
Mar 30, 2012Referred to the Subcommittee on Health.
Mar 29, 2012Referred to the House Committee on Energy and Commerce.

Vote on This Bill

-% Users Support Bill

0 in favor / 0 opposed
 

Send Your Rep a Letter

about this bill Support Oppose Tracking
Track with MyOC